Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1998 Jan;123(1):23–30. doi: 10.1038/sj.bjp.0701575

Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action

A E Busch 1,2,*, B Eigenberger 1, N K Jurkiewicz 3, J J Salata 3, A Pica 4, H Suessbrich 1, F Lang 1
PMCID: PMC1565134  PMID: 9484850

Abstract

  1. The class III antiarrhythmic azimilide has previously been shown to inhibit IKs and IKr in guinea-pig cardiac myocytes and IKs (minK) channels expressed in Xenopus oocytes. Because HERG channels underly the conductance IKr in human heart, the effects of azimilide on HERG channels expressed in Xenopus oocytes were the focus of the present study.

  2. In contrast to other well characterized HERG channel blockers, azimilide blockade was reverse use-dependent, i.e., the relative block and apparent affinity of azimilide decreased with an increase in channel activation frequency. Azimilide blocked HERG channels at 0.1 and 1 Hz with IC50 s of 1.4 μM and 5.2  μM respectively.

  3. In an envelope of tail test, HERG channel blockade increased with increasing channel activation, indicating binding of azimilide to open channels.

  4. Azimilide blockade of HERG channels expressed in Xenopus oocytes and IKr in mouse AT-1 cells was decreased under conditions of high [K+]e, whereas block of slowly activating IKs channels was not affected by changes in [K+]e.

  5. In summary, azimilide is a blocker of cardiac delayed rectifier channels, IKs and HERG. Because of the distinct effects of stimulation frequency and [K+]e on azimilide block of IKr and IKs channels, we conclude that the relative contribution of block of each of these cardiac delayed rectifier channels depends on heart frequency. [K+]e and regulatory status of the respective channels.

Keywords: Azimilide, HERG, KvLQT1, IsK (minK), IKr, IKs, K+ channel, arrhythmia, torsades de pointes

Full Text

The Full Text of this article is available as a PDF (389.0 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES